Quironsalud Madrid
| تركيا | إسبانيا | ألمانيا | |
| علاج سرطان الثدي بالبروتون | من $30,000 | من $85,000 | من $85,000 |
| علاج سرطان البروستاتا بالبروتون | من $30,000 | من $70,000 | من $70,000 |
| العلاج بالبروتون (انظر العلاج بحزم البروتون) | من $70,000 | من $25,458 | من $85,000 |
| العلاج الكيميائي لسرطان الثدي | من $1,200 | من $3,500 | من $4,500 |
| استئصال العظام | من $8,000 | من $20,000 | من $30,000 |
يقود البروفيسور جوان كارليس غالسيران وحدة الأورام البولية التناسلية، وأورام الجهاز العصبي المركزي، والساركوما، والأورام مجهولة الأصل في مستشفى جامعة فال دي هيرون، مع التخصص في حالات الساركوما المعقدة.
أخصائي جراحة العظام والكسور في مستشفى جامعة نافارا.
Standard treatment for chondrosarcoma in Spain centers on complete surgical resection with wide negative margins. Spanish oncology teams follow strict protocols established by the Spanish Group for Research on Sarcoma. Surgery remains primary because these tumors often resist conventional chemotherapy and radiation therapies.
Bookimed Expert Insight: Spanish oncology centers like Proton Therapy Centre Quironsalud and Centro Médico Teknon provide a specific advantage for complex axial skeleton tumors. While standard surgery is common globally, Spain has integrated the Proteus ONE proton system specifically for unresectable chondrosarcomas. Data shows these centers attract international patients by combining JCI-accredited surgical precision with highly specialized radiation that protects nearby vital organs. For patients with skull-base involvement, these bundled diagnostic and therapy packages offer a streamlined path to treatments not available in many other European regions.
Spain offers advanced proton beam therapy for chondrosarcoma at specialized oncology centers in Madrid. Facilities like Proton Therapy Centre Quironsalud utilize the Proteus ONE system. This technology delivers high-precision radiation to bone tumors while protecting critical structures like the brainstem and spinal cord.
Bookimed Expert Insight: While Spain has several top-tier oncology centers, specialized proton therapy for rare sarcomas is concentrated in Madrid. A notable differentiator is the clinical experience of the specialists. For example, Dr. Carme Ares at Quironsalud trained at Massachusetts General Hospital in Boston, a global pioneer in proton technology. This specific expertise in rare tumors is often more critical than the machine itself for successful outcomes.
Patient Consensus: Patients note that while the technology exists, access depends on a multidisciplinary tumor board review. Many emphasize that verifying the center's regular experience with rare bone sarcomas is vital for peace of mind.
Spain hosts several centers of excellence for chondrosarcoma recognized by the Ministry of Health (CSUR) and international bodies like JCI. Key institutions include Vall d Hebron University Hospital, Hospital Universitario La Paz, and private leaders like Clinica Universidad de Navarra and Teknon Medical Center.
Bookimed Expert Insight: Data suggests a geographical divide in specialized treatments. Madrid centers like Quironsalud Madrid focus heavily on high-precision radiotherapy. In contrast, Barcelona facilities like Centro Medico Teknon and Hospital Quiron Barcelona lead in high-volume surgical oncology. Patients requiring complex limb-sparing surgery should look for centers performing over 23,000 annual operations to ensure deep surgical expertise.
Patient Consensus: Patients emphasize that a specialized sarcoma tumor board review is essential. They note that biopsy planning must be handled by the specific orthopedic oncology team performing the final surgery to ensure the best outcome.
International patients can enroll in clinical trials for metastatic chondrosarcoma in Spain. Specialized networks like the Spanish Sarcoma Research Group (GEIS) manage these opportunities. Enrollment depends on trial protocols, biomarker profiles, and pathology reports. Access is determined on a case-by-case basis at JCI-accredited centers.
Bookimed Expert Insight: Spain ranks 7th globally in our network for complex oncology requests. While Quironsalud Madrid offers free treatment through trials, these spots are highly competitive. Patients should prioritize clinics with dedicated research units like Teknon or HM Madrid. These institutions handle over 23,000 operations yearly and have deeper trial infrastructure.
Patient Consensus: Patients note that being eligible to apply differs from being accepted for treatment. Having all pathology and molecular tests translated into Spanish significantly speeds up the review process.